Guidehouse Expands Chennai Footprint with New 250k sq. ft. Facility
State-of-the-art campus at Keppel One Paramount to host 5,000 employees across key operations; Facility will serve as a center for...
Month: May 2025
Pediatrics Open Science Launches Webinar for Early-Career Researchers
Pediatrics Open Science webinar will offer insights on manuscript preparation for those eager to navigate the world of academic publishing ...
Vitalograph and Thorasys Forge Strategic Partnership to Expand Respiratory Diagnostics with Launch of Tremoflo® C2 Oscillometer
SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- At the American Thoracic Society (ATS) Annual Conference, Vitalograph and Thorasys announced a...
Baird Medical Engages Global Clinical Leaders at AAES 2025
NEW YORK, May 19, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a...
Dazos Raises $25 Million Series A to Empower Behavioral Health Providers
BOCA RATON, Fla., May 19, 2025 /PRNewswire/ -- Dazos, the all-in-one CRM platform for behavioral health providers, has raised $25...
LifeLoop unites 26 years of iN2L engagement leadership in senior living with the transformative power of AI
Senior living technology innovator's new release caps off a trio of breakthrough AI solutions designed to streamline staff workflows and...
Olympus Appoints Slawek Kierner as Chief Digital Officer – Smart Connected Care
Newly created role to lead digital innovation TOKYO, May 19, 2025 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to...
New initiative delivers CPR education through ADP Mobile Solutions app to build Nation of Lifesavers™
ADP supports American Heart Association goal to prepare more workers to respond to cardiac emergencies DALLAS and ROSELAND, N.J., May 19,...
Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging
SAN DIEGO, May 19, 2025 /PRNewswire/ -- Cortechs.ai, a global leader in AI-driven neuroimaging solutions, today announced a strategic collaboration...
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced...
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move...
Arbor Biotechnologies Appoints Don Haut, Ph.D., as Chief Business Officer
Seasoned biopharma executive brings more than twenty years of business development, strategy, and operational expertise to Arbor’s leadership teamCAMBRIDGE, Mass.,...
Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
Press release – No. 9 / 2025 Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related...
Porch Light Health Partners with CHESS Health to Offer a Contingency Management Incentives Program to Boost SUD Treatment Outcomes
DENVER, May 19, 2025 (GLOBE NEWSWIRE) -- Porch Light Health (PLH) has partnered with CHESS Health to use its innovative,...
MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results
TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in...
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as...
Phase II Data in Treatment-Naïve Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy
--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria...
Lifeward Names Mark Grant as New CEO
Industry veteran brings 30 years of commercial leadership experienceMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward...
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits...
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first...